Nemaura Medical Announces Submission to German Authorities for Reimbursement of its Glucose Monitoring Device
March 11, 2021 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, March 11, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical to Present at Maxim Group’s Inaugural Emerging Growth Virtual Conference
March 10, 2021 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, March 10, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Appoints Industry Veteran Alistair Longmuir as Advisor on Global Product Manufacture Strategy
March 04, 2021 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, March 04, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Corporate Update
February 16, 2021 08:30 ET
|
Nemaura Medical, Inc
Loughborough, England, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Secures $20 Million Non-Dilutive Loan to Accelerate Business Growth
February 11, 2021 08:45 ET
|
Nemaura Medical, Inc
Loughborough, England, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Appoints Thomas Mortensen as Head of E.U. Commercial Operations and Marketing
February 04, 2021 08:30 ET
|
Nemaura Medical, Inc
Loughborough, England, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...